Boai NKY Medical Holdings Ltd. (SHE:300109)
China flag China · Delayed Price · Currency is CNY
10.74
-0.25 (-2.27%)
Nov 6, 2026, 3:04 PM CST

Boai NKY Medical Holdings Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
123.84190.09349.68493.03291.46207.05
Depreciation & Amortization
101.22103.1102.0974.2261.9471.88
Other Amortization
12.9811.12.954.773.94.32
Loss (Gain) From Sale of Assets
-2.46-2.46-0.09-0.040.870.46
Asset Writedown & Restructuring Costs
41.6541.6546.370.360.1160.63
Loss (Gain) From Sale of Investments
-3.28-3.2812.231.0737.83-201.64
Provision & Write-off of Bad Debts
---9.6145.8211.7
Other Operating Activities
54.613.336.49-5.03-2.2536.49
Change in Accounts Receivable
88.4188.41-27.84-57.81-163.959.25
Change in Inventory
59.0959.09-71.62-61.94-10.26-39.3
Change in Accounts Payable
-171.43-171.43-181.5232.2710.25-104.68
Change in Other Net Operating Assets
22.6522.6528.58-4.23-3.7-0.63
Operating Cash Flow
323.14338.11256.03488.25251.7743.44
Operating Cash Flow Growth
73.41%32.06%-47.56%93.93%479.57%-83.72%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-174.31-220.42-274.68-377.88-266-228.32
Sale of Property, Plant & Equipment
10.11130.040.170.4215.81
Divestitures
0.75-4.958.9301,970
Investment in Securities
304.68260.43174.56-175.86549.93254.98
Other Investing Activities
-291.1----587.08-482.5
Investing Cash Flow
-149.8753.01-95.14-544.64-302.721,530

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-445.46626.7914.9826.68607.68
Short-Term Debt Repaid
------30
Long-Term Debt Repaid
--568.56-238.43-27.34-36.33-1,289
Lease Payments
-1.74-1.74-1.45-1.37-1.3-6.41
Total Debt Repaid
-173.89-568.56-238.43-27.34-36.33-1,319
Net Debt Issued (Repaid)
246.35-123.11388.35-12.37-9.65-711.66
Issuance of Common Stock
-1.350.9-15.1119.4
Repurchase of Common Stock
---1.9-7.08-400.07-3.4
Common Dividends Paid
-101.58-129.32-328.78-164.26-169.97-41.49
Other Financing Activities
-349.150.040.06---
Financing Cash Flow
-204.38-251.0558.63-183.71-564.59-637.15

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
0.8312.14.872.023.862.58
Net Cash Flow
-30.28152.18224.4-238.07-611.68938.42

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
148.82117.69-18.65110.37-14.23-184.88
Free Cash Flow Growth
------
Free Cash Flow Margin
12.33%9.99%-1.16%6.97%-0.96%-15.15%
Free Cash Flow Per Share
0.260.20-0.030.19-0.02-0.31
Levered Free Cash Flow
356.49240.11-72.5524.6-25.77136.38
Unlevered Free Cash Flow
358.46244.85-68.1525.89-24.13159.96
Free Cash Flow After Leases
147.09115.95-20.11109-15.53-191.28

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
57.1957.4783.63240.09147.8962.9
Change in Working Capital
-5.41-5.41-263.69-89.73-187.92-147.44